Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

Clinical trial NCT05753930 · RECRUITING

Trial details

NCT number: NCT05753930
Sponsor: Hansa Biopharma AB
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Transplantation in Highly Sensitized Patients

Start date: 2023-06-02
Primary completion: 2027-02-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.